Melatonin and melatonin receptor agonists reduce delirium risk in hospitalized patients
In a network meta-analysis of 33 randomized controlled trials involving 5045 patients, melatonin and melatonin receptor agonists were associated with a 23% lower risk of delirium compared with non-active control conditions (RR=0.77, 95% CI: 0.64-0.92). The effect was more evident in non-ICU and surgical populations, but the certainty of evidence was low to moderate.
Evidence Score
Study Evidence
Study 1. Sleep-modulating pharmacological interventions for delirium prevention: a systematic review and a network meta-analysis of randomized controlled trials.
observationalChen H, Zhao Y, Li Y, Chen W, Tan X ยท Sleep medicine reviews (2026)
Result:
Mechanism Graph
Limitations
- โ Certainty of evidence ranged from low to moderate
- โ Limited direct comparisons between active interventions
- โ Agent-specific evidence base; findings may not generalize to all melatonin receptor agonists
Frequently Asked Questions
What is the effect of melatonin on delirium prevention?โผ
Melatonin and melatonin receptor agonists reduce delirium risk by 23% compared to control (RR=0.77, 95% CI: 0.64-0.92).
In which patient populations is melatonin most effective for delirium prevention?โผ
Subgroup analyses suggest the effect is more evident in non-ICU and surgical populations.
How does melatonin compare to suvorexant for delirium prevention?โผ
Both melatonin (RR=0.77) and suvorexant (RR=0.51) reduce delirium risk, but direct comparisons are limited.
Are benzodiazepines like midazolam effective for delirium prevention?โผ
No, midazolam-based benzodiazepines did not show a statistically significant reduction in delirium risk (RR=1.64, 95% CI: 0.81-3.31).
Products
Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.
References
- 1.Chen H, Zhao Y, Li Y, Chen W, Tan X. "Sleep-modulating pharmacological interventions for delirium prevention: a systematic review and a network meta-analysis of randomized controlled trials.." Sleep medicine reviews, 2026. PMID: 42673734 DOI: 10.1016/j.smrv.2026.102365